View in EDS

Impact of Tumor Size on Outcomes of Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA): > 3 cm Is No Absolute Contraindication.

Saved in:
Bibliographic Details
Title: Impact of Tumor Size on Outcomes of Hepatic Arteriography and C-Arm CT-Guided Ablation (HepACAGA): > 3 cm Is No Absolute Contraindication.
Authors: Wijnen N; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands. n.wijnen-5@umcutrecht.nl., Ruijs E; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Bruijnen RCG; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., de Bruijne J; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Hagendoorn J; Department of Surgery, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Bol GM; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA, USA., Intven MPW; Department of Radiotherapy, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands., Smits MLJ; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX, Utrecht, The Netherlands.
Source: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2026 Jan; Vol. 49 (1), pp. 59-69. Date of Electronic Publication: 2025 Aug 26.
Publication Type: Journal Article
Journal Info: Publisher: Springer Verlag Country of Publication: United States NLM ID: 8003538 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-086X (Electronic) Linking ISSN: 01741551 NLM ISO Abbreviation: Cardiovasc Intervent Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-086X
DOI:10.1007/s00270-025-04167-8